We are live on ! Find out more

89 hedge funds and large institutions have $252M invested in Biote in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

110% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 10

100% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 9

40% more capital inflows, than outflows

Capital inflows: $76.5M | Capital outflows: $54.5M

14% more funds holding

Funds holding: 78 → 89 (+11)

5.75% more ownership

Funds ownership: 74.56% → 80.31% (+5.7%)

75% less funds holding in top 10

Funds holding in top 10: 4 → 1 (-3)

Holders
89
Holders Change
+11
Holders Change %
+14.1%
% of All Funds
1.4%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.02%
New
21
Increased
18
Reduced
9
Closed
10
Calls
$494​K
Puts
–
Net Calls
+$494​K
Net Calls Change
+$4​K

BTMD Hedge Fund Activity: Q1 2022 in Review

89 of the 6,366 institutional investors tracked by Wall St. Rank reported a position in Biote (BTMD) for Q1 2022, worth a combined $252M — up 10% from $228M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new BTMD positions and 10 closed out — a net gain of 11 holders — while 18 added to existing stakes and 9 trimmed.

The largest buyer was Taconic Capital Advisors, opening a new position worth an estimated $13.1M. The largest seller was Glazer Capital, exiting entirely with an estimated $28.8M sold.

  • 89 institutional investors held Biote (BTMD) as of Q1 2022, up from 78 in Q4 2021.
  • Funds reported $252M of Biote stock for Q1 2022, up 10% quarter-over-quarter.
  • 21 funds opened new Biote positions in Q1 2022 and 10 closed out, a net change of +11 holders.
  • The largest Biote buyer in Q1 2022 was Taconic Capital Advisors, an estimated $13.1M added.
  • The largest Biote seller in Q1 2022 was Glazer Capital, an estimated $28.8M sold.

Based on aggregated 13F filings for Q1 2022.